ArticleFrontiers in pharmacology2025

Targeting PGK1 as a Novel strategy to regulate the sensitivity of HER2 positive gastric cancer to lapatinib.

Xiaochen Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.